Shares of Aralez Pharmaceuticals Inc. (TSE:ARZ) rose 6% on Wednesday . The company traded as high as C$2.02 and last traded at C$1.89. Approximately 50,422 shares traded hands during mid-day trading, an increase of 19% from the average daily volume of 42,286 shares. The stock had previously closed at C$2.01.

TRADEMARK VIOLATION WARNING: “Aralez Pharmaceuticals Inc. (ARZ) Stock Price Up -6%” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.watchlistnews.com/aralez-pharmaceuticals-inc-arz-stock-price-up-6/1722912.html.

About Aralez Pharmaceuticals

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Receive News & Ratings for Aralez Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.